What will be the domestic selling price of trametinib in 2025?

As of2025, Trametinib (Trametinib, trade name "Meigenin") has been officially launched in China and has been included in the national medical insurance directory, which greatly facilitates the acquisition of drugs for patients with advanced melanoma and other related tumors. In terms of specifications, trametinib mainly comes in two common packages in China: 0.5mg 30 tablets and 2mg 30 tablets. According to the current public selling price information, the price of 0.5mg30 tablets is about three to four thousand yuan, while the price of 2mg30 tablets is relatively high, between more than 9,000 to more than 10,000 yuan.

It should be noted that since trametinib has been included in medical insurance, the actual payment amount will vary due to differences in local medical insurance policies. Usually after medical insurance reimbursement, the patient's out-of-pocket portion will be significantly reduced. Especially for patients who have applied for major disease medical insurance or enjoy the drug reimbursement policy of designated hospitals, the financial burden will be significantly reduced. Therefore, it is recommended that patients or family members go to the local hospital pharmacy or medical insurance bureau to learn about the specific reimbursement ratio and actual drug purchase cost.

In foreign markets, there are also certain differences in the price of trametinib. For example, the original research version 2mg*30 tablets from Turkey are currently priced at about 7,000 to 8,000 yuan, which is slightly lower than the domestic original research price. For some patients who do not have medical insurance coverage or who want to reduce treatment costs, obtaining Turkish original drugs from overseas legal channels is an alternative that can be considered. However, it is necessary to ensure that the purchasing channels are formal to avoid the risk of counterfeit drugs.

In addition, the Lao Ministry of Health has currently approved the legal marketing of generic trametinib drugs. Its drug ingredients are highly consistent with the original drug, and it has been recognized as an effective alternative version after clinical verification. The price of this kind of Lao version of generic drugs is more affordable. 2mg*30 tablets are priced at about more than 1,000 yuan, and are favored by some patients. Although generic drugs have more advantages in terms of price, it is still recommended that patients evaluate the risks and treatment needs under the guidance of a professional doctor before choosing to ensure efficacy and drug safety.

Reference materials:https://go.drugbank.com/drugs/DB08911